By Drug Target Review2023-10-04T14:00:03
Researchers have found that targeting chimeras with click-release proteolysis activates specific molecules that target cancer cells without harming health cells.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-18T14:47:08Z
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-03-23T14:46:21
Sponsored by Bio-Techne
2025-05-14T14:30:00
Sponsored by Abzena
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2024-01-10T08:23:16
Sponsored by BellBrook Labs
Site powered by Webvision Cloud